Affordable Access

Health reform and technology--what does it mean for us?

Authors
Type
Published Article
Journal
Biomedical instrumentation & technology / Association for the Advancement of Medical Instrumentation
Publication Date
Volume
29
Issue
6
Pages
476–478
Identifiers
PMID: 8574260
Source
Medline

Abstract

John Abele, Founder Chairman of Boston Scientific Corporation, spoke at AAMI's 30th Annual Meeting on 22 May in Anaheim, CA. His speech was part of AAMI's plenary session, "The Impact of a Reformed Health System on New Technology." After his speech, Abele joined three of AAMI's experts in a roundtable discussion on the topics he raised. See the BI&T Forum page 479 for their discussion. As a business entrepreneur and scientist, Abele is well versed in the topic of health reform and scientific advancements. He began his career with a degree in physics and philosophy, then moved into the health care field because of his fascination with medical devices and technologies. He has spent years working as an engineer, a salesperson, a general manager, and a partner in a research and development company. He was a cofounder of AAMI in 1965. Boston Scientific's roots trace back to 1969, when Abele joined with Itzhak Bentov to build a company around a steerable catheter. The associated technology became a platform for many types of tools that could be used as alternatives to surgery in most organs of the body. Today, with over 5,000 employees, 4,000 products, and a worldwide presence, the original objective of developing products and procedures that reduce risk, trauma, cost, and time still applies. Abele is the author of many papers and book chapters, and he has lectured extensively on the technology of various medical devices and technical, social, economic, and political trends affecting health care. His major interests are science education and the process by which new technology is invented, developed, and introduced to society. The following article is based on Abele's presentation.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments